Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV001074670 | SCV001240262 | uncertain significance | Retinal dystrophy | 2019-03-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001577735 | SCV001805163 | likely pathogenic | not provided | 2019-09-30 | criteria provided, single submitter | clinical testing | Not observed in large population cohorts (Lek et al., 2016); Intronic +5 splice site variant predicted to result in an in-frame deletion of exon 29; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV001577735 | SCV005749044 | uncertain significance | not provided | 2025-01-21 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 29 of the ABCA4 gene. It does not directly change the encoded amino acid sequence of the ABCA4 protein. RNA analysis indicates that this variant induces altered splicing and may result in an absent or altered protein product. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individual(s) with ABCA4-related conditions (PMID: 33258285). ClinVar contains an entry for this variant (Variation ID: 866570). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant results in skipping of exon 29, and produces a non-functional protein and/or introduces a premature termination codon (PMID: 33258285). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |